Cargando…

Erratum: Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature

Detalles Bibliográficos
Autores principales:	Gao, Juehua, Gentzler, Ryan D., Timms, Andrew E., Horwitz, Marshall S., Frankfurt, Olga, Altman, Jessica K., Peterson, LoAnn C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696212/ https://www.ncbi.nlm.nih.gov/pubmed/26715529 http://dx.doi.org/10.1186/s13045-015-0228-z

Ejemplares similares

Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature
por: Gao, Juehua, et al.
Publicado: (2014)

GATA family transcriptional factors: emerging suspects in hematologic disorders
por: Gao, Juehua, et al.
Publicado: (2015)

Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS
por: List, A F, et al.
Publicado: (2015)

GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
por: Al Seraihi, Ahad F., et al.
Publicado: (2018)

GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects
por: Kotmayer, Lili, et al.
Publicado: (2022)

Inherited predisposition to MDS/AML
por: Rio Machin, Ana, et al.
Publicado: (2018)

Erratum to: Identity-by-descent-based heritability analysis in the Northern Finland Birth Cohort
por: Browning, Sharon R., et al.
Publicado: (2013)

ERRATUM: Author's Affiliation Correction. Heritabilities of Facial Measurements and Their Latent Factors in Korean Families
por: Kim, Hyun-Jin, et al.
Publicado: (2013)

IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)

Erratum: GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness
por: Lin, M-C, et al.
Publicado: (2017)

Erratum: miR-194-5p/BCLAF1 deregulation in AML tumorigenesis
por: Dell'Aversana, C, et al.
Publicado: (2017)

Age-related epigenetic drift in the pathogenesis of MDS and AML
por: Maegawa, Shinji, et al.
Publicado: (2014)

Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Hahn, Christopher N., et al.
Publicado: (2011)

Erratum to: indirect genetic effects contribute substantially to heritable variation in aggression-related traits in group-housed mink (Neovison vison)
por: Alemu, Setegn Worku, et al.
Publicado: (2014)

P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
por: Burkart, Madelyn, et al.
Publicado: (2023)

Erratum
por: Hughes, Avery, et al.
Publicado: (2020)

American Society of Hematology 2020 Podcast Collection: MDS and AML
por: Almeida, António
Publicado: (2021)

Recurrent transcriptional responses in AML and MDS patients treated with decitabine
por: Upadhyay, Pawan, et al.
Publicado: (2022)

Erratum: the National Institutes of Health and guidance for reporting preclinical research
por: Moher, David, et al.
Publicado: (2015)

Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients
por: Jensen, Oda, et al.
Publicado: (2022)

Malcovati L, Stevenson K, Papaemmanuil E, et al. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood. 2020;136(2):157-170.
Publicado: (2021)

Paclitaxel Induced MDS and AML: A Case Report and Literature Review
por: Bhatnagar, Udit Bhaskar, et al.
Publicado: (2016)

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy
por: Uy, Geoffrey L., et al.
Publicado: (2016)

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents
por: Livio, Pagano, et al.
Publicado: (2018)

Rewriting the rules for care of MDS and AML patients in the time of COVID-19
por: Raza, Azra, et al.
Publicado: (2020)

Erratum
por: Wincent, Josephine, et al.
Publicado: (2016)

Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
por: Przychodzen, Bartlomiej, et al.
Publicado: (2017)

Short Dysfunctional Telomere Is Highly Predictive of Dismal Outcome in MDS but Not in AML Patients
por: Menshawy, Nadia El, et al.
Publicado: (2020)

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
por: Rio-Machin, Ana, et al.
Publicado: (2020)

PB1793: NEUTROPHIL TO LYMPHOCYTE RATIO AS A PROGNOSTIC FACTOR IN AML AND MDS
por: Van Oorschot, V., et al.
Publicado: (2022)

Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution
por: Chang, Lixian, et al.
Publicado: (2022)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
por: Vaxevanis, Christoforos K., et al.
Publicado: (2022)

Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
por: Yang, Guancui, et al.
Publicado: (2022)

Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
por: Li, Hongjiao, et al.
Publicado: (2023)

Erratum to: Alternative Surfactants for Improved Efficiency of In Situ Tryptic Proteolysis of Fingermarks
por: Patel, Ekta, et al.
Publicado: (2015)

Rapid and robust reversion to essential thrombocythemia on treatment with Decitabine in a case of hydroxyurea‐induced t‐MDS/AML
por: Horton, Joshua D., et al.
Publicado: (2015)

GATA2 deficiency and related myeloid neoplasms
por: Wlodarski, Marcin W., et al.
Publicado: (2017)

Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
por: Foss, Francine, et al.
Publicado: (2017)

Erratum: Divergent activity of the gonadotropin-releasing hormone receptor gene promoter among genetic lines of pigs is partially conferred by nuclear factor (NF)-kB, specificity protein (SP)1-like and GATA-4 binding sites
por: McDonald, Emily A., et al.
Publicado: (2016)

Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
por: Huber, Sandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cp6sgrvr2hkkpl5ood2d9glhul